首页> 美国卫生研究院文献>PLoS Clinical Trials >Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance
【2h】

Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance

机译:从肿瘤中检测DNA突变过程特征的计算工具:性能回顾和经验比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutational signatures refer to patterns in the occurrence of somatic mutations that might be uniquely ascribed to particular mutational process. Tumour mutation catalogues can reveal mutational signatures but are often consistent with the mutation spectra produced by a variety of mutagens. To date, after the analysis of tens of thousands of exomes and genomes from about 40 different cancer types, tens of mutational signatures characterized by a unique probability profile across the 96 trinucleotide-based mutation types have been identified, validated and catalogued. At the same time, several concurrent methods have been developed for either the quantification of the contribution of catalogued signatures in a given cancer sequence or the identification of new signatures from a sample of cancer sequences. A review of existing computational tools has been recently published to guide researchers and practitioners through their mutational signature analyses, but other tools have been introduced since its publication and, a systematic evaluation and comparison of the performance of such tools is still lacking. In order to fill this gap, we have carried out an empirical evaluation of the main packages available to date, using both real and simulated data. Among other results, our empirical study shows that the identification of signatures is more difficult for cancers characterized by multiple signatures each having a small contribution. This work suggests that detection methods based on probabilistic models, especially EMu and bayesNMF, have in general better performance than NMF-based methods.
机译:突变签名是指发生体细胞突变的模式,这种模式可能独特地归因于特定的突变过程。肿瘤突变目录可以揭示突变特征,但通常与各种诱变剂产生的突变谱一致。迄今为止,在对来自约40种不同癌症类型的成千上万个外显子组和基因组进行分析后,已鉴定,验证和分类了数十种以基于96种三核苷酸的突变类型的独特概率谱为特征的突变特征。同时,已经开发了几种并发方法,用于量化给定癌症序列中分类特征的贡献或从癌症序列样本中鉴定新特征。最近已经发表了对现有计算工具的综述,以指导研究人员和从业人员进行突变特征分析,但是自从其发表以来就引入了其他工具,并且仍然缺乏对这些工具性能的系统评价和比较。为了填补这一空白,我们使用实际数据和模拟数据对迄今为止可用的主要软件包进行了经验评估。在其他结果中,我们的经验研究表明,特征为多种特征,每个特征贡献不大的癌症的特征识别更加困难。这项工作表明,基于概率模型(尤其是EMu和bayesNMF)的检测方法通常比基于NMF的方法具有更好的性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号